Pacific Clinical Research Medical Group

Pacific Clinical Research Medical Group

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Pacific Clinical Research Medical Group is a long-established, private clinical research site organization that conducts Phase II-IV clinical trials for pharmaceutical sponsors, predominantly in psychiatry and neurology. Its business model is service-based, generating revenue by contracting with sponsors to recruit patients, administer trial protocols, and collect data. The company operates from a single physical site in Southern California and leverages its experienced medical team to attract trial participants by offering complementary care and medication. It occupies a niche as an investigative site within the broader clinical trial ecosystem.

PsychiatryNeurology

Technology Platform

Operational platform as a specialized clinical trial site with expertise in patient recruitment, protocol execution, and data collection for CNS disorders. No proprietary therapeutic or diagnostic technology.

Opportunities

The growing global CNS clinical trial market and persistent patient recruitment bottlenecks create strong demand for reliable, specialized sites.
The trend towards hybrid decentralized trials allows an opportunity to leverage local patient relationships while incorporating remote tools to enhance trial participation and retention.

Risk Factors

High dependency on winning contracts from a limited pool of pharmaceutical sponsors and intense competition from larger site networks.
Operational concentration risk from being a single-site organization and inherent risks in patient recruitment timelines for complex psychiatric trials.

Competitive Landscape

Competes with other independent clinical research sites, large site management organizations (SMOs) like ICON plc (PRA Health Sciences), and academic medical centers. Differentiation is based on therapeutic expertise in psychiatry, patient recruitment speed, and a long-standing operational track record in a key geographic market.